Evidence map›Paper›PMID 27614084›Full record

ArticleAddiction (Abingdon, England)2017

Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis.

Andrew McAuley, Janet Bouttell, Lee Barnsdale, Daniel Mackay, Jim Lewsey, Carole Hunter, Mark Robinson

Open access · hybridAbstract read
In one paragraph

Article in Addiction (Abingdon, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.Health technology assessment (Winchester, England) · 2024
    Trial
  2. Toxidromes.Nature reviews. Disease primers · 2026
    Review
  3. BMJ open · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Frequently asked questions about naloxone: Part 3.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Andrew McAuleyHealth Protection Scotland, Meridian Court, Glasgow, UK.
Janet BouttellInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Lee BarnsdaleNHS National Services Scotland, Information Services Division, Gyle Square, Edinburgh, UK.
Daniel MackayInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Jim LewseyInstitute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Carole HunterNHS Greater Glasgow and Clyde, Possilpark Health and Care Centre, Glasgow, UK.
Mark RobinsonPublic Health Science Directorate, NHS Health Scotland, Meridian Court, Glasgow, UK.
University of Glasgow · GBHealth Protection Scotland · GBNational Health Service Scotland · GBNHS Greater Glasgow and Clyde · GBPublic Health Scotland · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsIt has been suggested that distributing naloxone to people who inject drugs (PWID) will lead to fewer attendances by emergency medical services at opioid-related overdose incidents if peer administration of naloxone was perceived to have resuscitated the overdose victim successfully. This study evaluated the impact of a national naloxone programme (NNP) on ambulance attendance at opioid-related overdose incidents throughout Scotland. Specifically, we aimed to answer the following research questions: is there evidence of an association between ambulance call-outs to opioid-related overdose incidents and the cumulative number of 'take-home naloxone' (THN) kits in issue; and is there evidence of an association between ambulance call-outs to opioid-related overdose incidents in early adopter (pilot) or later adopting (non-pilot) regions and the cumulative number of THN kits issued in those areas?

designControlled time-series analysis.

settingScotland, UK, 2008-15.

participantsPre-NNP implementation period for the evaluation was defined as 1 April 2008 to 31 March 2011 and the post-implementation period as 1 April 2011 to 31 March 2015. In total, 3721 ambulance attendances at opioid-related overdose were recorded for the pre-NNP implementation period across 158 weeks (mean 23.6 attendances per week) and 5258 attendances across 212 weeks in the post-implementation period (mean 24.8 attendances per week).

interventionScotland's NNP; formally implemented on 1 April 2011. MEASUREMENTS: Primary outcome measure was weekly incidence (counts) of call-outs to opioid-related overdoses at national and regional Health Board level. Data were acquired from the Scottish Ambulance Service (SAS). Models were adjusted for opioid replacement therapy using data acquired from the Information Services Division on monthly sums of all dispensed methadone and buprenorphine in the study period. Models were adjusted further for a control group: weekly incidence (counts) of call-outs to heroin-related overdose in the London Borough area acquired from the London Ambulance Service.

findingsThere was no significant association between SAS call-outs to opioid-related overdose incidents and THN kits in issue for Scotland as a whole (coefficient 0.009, 95% confidence intervals = -0.01, 0.03, P = 0.39). In addition, the magnitude of association between THN kits and SAS call-outs did not differ significantly between pilot and non-pilot regions (interaction test, P = 0.62).

conclusionsThe supply of take-home naloxone kits through a National Naloxone Programme in Scotland was not associated clearly with a decrease in ambulance attendance at opioid-related overdose incidents in the 4-year period after it was implemented in April 2011.

Indexed as

AmbulancesDrug OverdoseEmergency Medical ServicesHumansNaloxoneNarcotic AntagonistsOpioid-Related DisordersScotlandSubstance Abuse, IntravenousNaloxoneNarcotic AntagonistsAmbulancecontrolled time-seriesevaluationnaloxoneopioidoverdose

Identifiers

PMID27614084
PMCPMC5248605
OpenAlexW2519969994

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.